Peter Zandstra is Co-Founder and CTO at ExCellThera, a clinical stage biotechnology company leading the development of robust and cost effective ways of growing blood stem cells for therapeutic use. He is also Executive Director Medicine by Design.
Andrea Palmer is a young entrepreneur, autism health advocate, and exponential tech geek. Founder and CEO of Awake Labs, she is passionate about advancing quantified health care and democratizing technology. Andrea dabbles in MMA and Brazilian Jiu Jitsu when she isn’t running her company and travelling around the world.
Andre Marziali is a leading innovator, educator, and entrepreneur with over 20 years’ experience in developing tools for life science research and technologies for nucleic acid analysis, Andre developed Boreal Genomics with colleagues from The University of British Columbia in 2007. Andre also loves driving Ferrari’s in his spare time.
Lara Boyd is a cutting edge researcher and director of UBC’s Brain Behaviour Lab. Lara’s work focuses on understanding neuroplastic changes in the brain with the goal of refining rehabilitation interventions for people affected by stroke. An accomplished Neuroscientist and Physical Therapist, Dr. Boyd dreams about finding the time to earn her second PhD in English Literature.
Tim Salcudean is a professor at The University of British Columbia in the Department of Electrical and Computer Engineering. Tim’s research interests include medical robotics, tele-operation and virtual environments. In his career he has 23 issued patents and his sabbaticals in France were allegedly motivated by a love of red wines and cheese.
Marc Parlange, P.Eng., is a Dean and a Professor in the Department of Civil Engineering. He has received numerous awards for his academic achievements, and is also active in addressing water resources challenges in remote communities through his research on hydrology and climate change. He has received numerous awards for his academic achievements.
Dr. Dermot Kelleher is the author of 300 publications and 14 patents. His research examines the immune response to many of the leading causes of gastrointestinal infectious disease worldwide. With a strong commitment to innovation and collaboration, Dr. Kelleher has also founded several companies.